| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| GeneDx Holdings Corp. | Director | Class A Common Stock | 27.7K | $783K | $28.31 | Jun 20, 2024 | Direct |
| GeneDx Holdings Corp. | Director | Restricted Stock Unit | 12.9K | $366K | $28.31 | Jun 26, 2024 | Direct |
| OPKO HEALTH, INC. | Director | Common Stock | 325K | $318K | $0.98 | Jan 5, 2024 | Direct |
| Fluent, Inc. | Director | Common Stock | 50.7K | $173K | $3.42 | Jun 5, 2024 | Direct |
| ASENSUS SURGICAL, INC. | Director | Common Stock | 0 | $0 | $0.25 | Aug 22, 2024 | Direct |
| OPKO HEALTH, INC. | Director | Stock Option (Right to Buy) | 60K | Mar 28, 2024 | Direct | ||
| Cocrystal Pharma, Inc. | Director | Stock Options (Right to Buy) | 7.33K | Jul 18, 2023 | Direct | ||
| GP STRATEGIES CORP | Director | Common Stock | 0 | $20.85 | Oct 14, 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ASXC | ASENSUS SURGICAL, INC. | Aug 22, 2024 | 1 | $0 | 4 | Aug 22, 2024 | Director |
| WGS | GeneDx Holdings Corp. | Jun 26, 2024 | 1 | $0 | 4 | Jun 27, 2024 | Director |
| WGS | GeneDx Holdings Corp. | Jun 20, 2024 | 2 | $0 | 4 | Jun 24, 2024 | Director |
| FLNT | Fluent, Inc. | Jun 5, 2024 | 1 | $0 | 4 | Jul 2, 2024 | Director |
| WGS | GeneDx Holdings Corp. | May 2, 2024 | 2 | $0 | 4 | May 3, 2024 | Director |
| OPK | OPKO HEALTH, INC. | Mar 28, 2024 | 0 | $0 | 4 | Mar 29, 2024 | Director |
| OPK | OPKO HEALTH, INC. | Jan 5, 2024 | 2 | $23.4K | 4 | Jan 5, 2024 | Director |
| OPK | OPKO HEALTH, INC. | Nov 13, 2023 | 4 | $32.5K | 4 | Nov 14, 2023 | Director |
| WGS | GeneDx Holdings Corp. | Nov 8, 2023 | 1 | $14.9K | 4 | Nov 8, 2023 | Director |
| WGS | GeneDx Holdings Corp. | Aug 17, 2023 | 1 | $25.5K | 4 | Aug 18, 2023 | Director |
| WGS | GeneDx Holdings Corp. | Jul 21, 2023 | 2 | $0 | 4 | Jul 25, 2023 | Director |
| COCP | Cocrystal Pharma, Inc. | Jul 18, 2023 | 1 | $0 | 4 | Jul 20, 2023 | Director |
| OPK | OPKO HEALTH, INC. | Jun 22, 2023 | 1 | $0 | 4 | Jun 23, 2023 | Director |
| FLNT | Fluent, Inc. | Jun 7, 2023 | 1 | $0 | 4 | Jun 14, 2023 | Director |
| ASXC | ASENSUS SURGICAL, INC. | Jun 6, 2023 | 1 | $0 | 4 | Jun 8, 2023 | Director |
| WGS | GeneDx Holdings Corp. | May 18, 2023 | 1 | $29.5K | 4 | May 22, 2023 | Director |
| WGS | GeneDx Holdings Corp. | May 2, 2023 | 2 | $0 | 4 | May 4, 2023 | Director |
| FLNT | Fluent, Inc. | Oct 6, 2022 | 1 | $0 | 4 | Oct 12, 2022 | Director |
| FLNT | Fluent, Inc. | Oct 6, 2022 | 0 | $0 | 3 | Oct 12, 2022 | Director |
| COCP | Cocrystal Pharma, Inc. | Jul 25, 2022 | 1 | $0 | 4 | Aug 3, 2022 | Director |
| OPK | OPKO HEALTH, INC. | Jul 14, 2022 | 1 | $0 | 4 | Jul 15, 2022 | Director |
| ASXC | ASENSUS SURGICAL, INC. | Jun 14, 2022 | 1 | $0 | 4 | Jun 15, 2022 | Director |
| WGSWW | Sema4 Holdings Corp. | May 2, 2022 | 1 | $0 | 4/A | May 6, 2022 | Director |
| WGSWW | Sema4 Holdings Corp. | Apr 29, 2022 | 0 | $0 | 3 | May 2, 2022 | Director |
| GPX | GP STRATEGIES CORP | Oct 14, 2021 | 1 | -$1.17M | 4 | Oct 18, 2021 | Director |
| GPX | GP STRATEGIES CORP | Sep 30, 2021 | 1 | $0 | 4 | Oct 4, 2021 | Director |
| COCP | Cocrystal Pharma, Inc. | Aug 20, 2021 | 1 | $41.1K | 4 | Aug 23, 2021 | Director |
| COCP | Cocrystal Pharma, Inc. | Jul 16, 2021 | 1 | $0 | 4 | Jul 20, 2021 | Director |
| ASXC | ASENSUS SURGICAL, INC. | Jun 30, 2021 | 2 | $0 | 4 | Jul 2, 2021 | Director |
| GPX | GP STRATEGIES CORP | Jun 30, 2021 | 1 | $0 | 4 | Jul 1, 2021 | Director |
| OPK | OPKO HEALTH, INC. | Jun 24, 2021 | 1 | $0 | 4 | Jun 25, 2021 | Director |
| COCP | Cocrystal Pharma, Inc. | May 27, 2021 | 0 | $0 | 3 | Jun 2, 2021 | Director |